Video & Transcript Research : 'psychoactive cannabinoids'

Page 7 of 13
FL

Florida 2026 4th Special Session

February 12, 2026 - 09:15 AM

Transcript Highlights:
  • Are there other psychoactive...
MN

Minnesota 2025-2026 Regular Session

House Commerce Finance and Policy Committee 4/2/25

Commerce Finance and Policy

Transcript Highlights:
  • There are a few other cleanup provisions in there related to adjustments to the amount of cannabinoid
  • There are a few other cleanup provisions in there related to adjustments to the amount of cannabinoid
  • I also own a cannabinoid emulsion company and sit on the board of the Hemp Beverage Alliance, the leading
  • The number one issue is the limits on non-intoxicating cannabinoids, which everyone has talked about
  • The first issue is the limits on non-intoxicating cannabinoids, which everyone has talked about already
HI

Hawaii 2025 Regular Session

HHS-CPN, CPN, CPN DEFER Public Hearings 03-19-2025

Health and Human Services

Transcript Highlights:
  • point out to the committee significant issues with enforcement in the area of hemp and synthetic cannabinoids
  • discussed what is necessary to increase the enforcement of the illegal hemp products and the illegal cannabinoids
  • so we are just applying them now to the medical cannabis framework by uniformly regulating all cannabinoids
  • so we are just applying them now to the medical cannabis framework by uniformly regulating all cannabinoids
  • uniformly cannabis uh framework by uniformly regulating<00:46:20.160> all Regulating all cannabinoids
Keywords: 912, senate, all
Summary: The committee heard testimony on HB 302, which would expand access to medical cannabis by removing the in-person provider-patient relationship requirement and related restrictions. The Department of Health supported the bill, and multiple advocates and organizations testified in support, including the ACLU of Hawaii, Hawaii Alliance for Cannabis Reform, Marijuana Policy Project, and others. Supporters said the measure would improve access for patients, especially on outer islands, and some urged broader amendments allowing providers to certify cannabis for any medical condition and to speed registration and treat in-state and out-of-state patients equally. No opposition was heard, and the bill was left with no questions after testimony. The committee also heard HB 1052 HD1, which clarifies that the Public Utilities Commission may use universal service fund monies to provide free telecommunications access for individuals with print disabilities. Testimony was uniformly supportive from the DCCA Division of Consumer Advocacy, the State Council on Developmental Disabilities, the Department of Human Services, the Public Utilities Commission, and the National Federation of the Blind of Hawaii. Witnesses described the program as an important accessibility service that has been operating under prior appropriations and should continue under the universal service program. HB 1482, relating to controlled substances and hemp/synthetic cannabinoids, drew support from the Department of Law Enforcement, Department of Health, Honolulu Police Department, and others, with some comments from the Attorney General’s office. Supporters said the bill would clarify that delta-8 THC is a controlled substance and help enforcement against illegal hemp products and synthetic cannabinoids. Testimony and questioning focused on the need for better lab testing capacity, retail registry and age-gating, seizure authority, nuisance abatement, and possible use of special funds or appropriations to support enforcement. Members also discussed enforcement of illegal hemp businesses and whether additional funding or statutory changes would be needed. Finally, the committee took up HB 712, a 340B drug-discount measure affecting safety-net providers and contract pharmacies. Hospitals, health centers, and provider groups testified in support, saying the bill would protect access to discounted drugs and preserve funding for services such as chronic disease management, transportation, and specialty care. Pharmaceutical-industry representatives opposed the bill or sought amendments, arguing the 340B program has expanded beyond its original intent and lacks transparency, and they requested reporting or audit-like provisions to verify claims and revenues. Members questioned both sides about alleged abuse, the growth of contract pharmacies, and whether the bill should include transparency requirements before moving forward.
NH

New Hampshire 2026 Regular Session

House Criminal Justice and Public Safety (03/18/2026)

Criminal Justice and Public Safety

Transcript Highlights:
  • So, people expected that the federal government would step up to regulate CBD and other cannabinoids.
  • Nothing about inhalable uh psychoactive substances. >> See no further questions.
  • 34:16.240> inhalable Nothing about inhalable Nothing about inhalable uh<02:34:18.479> psychoactive
  • uh psychoactive substances. uh psychoactive substances.
Keywords: 1189, house, all
MN

Minnesota 2025-2026 Regular Session

House Ways and Means Committee 5/15/26 - Part 2

Ways and Means

Transcript Highlights:
  • We also have a Representative West provision that clarifies how combined cannabinoids are calculated,
  • whether or not the named cannabinoids in law can be stacked or if it's in each.
  • whether or not the named cannabinoids in law can be stacked or if it's in each.
  • whether or not the named cannabinoids in law can be stacked or if it's in each.
  • , whether or not the named cannabinoids in law can be stacked or if it's in each.
Keywords: 1183, house
MN

Minnesota 2025 1st Special Session

House Commerce Finance and Policy Committee 2/11/25

Commerce Finance and Policy

Transcript Highlights:
  • The third is the hemp-derived cannabinoid products.
  • We picked up the hemp-derived cannabinoid program, which began at the Board of Pharmacy, then was at
  • The third is the hemp-derived cannabinoid products.
  • <00:18:23.000> products<00:18:24.000> uh the hemp deriv cannabinoid products uh the
  • As I mentioned, we inherited the hemp-derived cannabinoid program from the Department of Health.
Keywords: 1183, house
Summary: The Minnesota House Commerce Committee held its inaugural meeting with Chair Tim O’Driscoll and co-chair Representative Greg Davids opening the session and inviting members to introduce themselves. Members briefly described their districts, business backgrounds, and priorities, with recurring themes including small business competitiveness, insurance and health care access, property and real estate issues, agriculture, and making Minnesota easier to do business in. Committee staff also introduced themselves and reminded members and testifiers about sign-in procedures and microphone use. The committee then heard an overview from Eric Toell, interim director of the Office of Cannabis Management, on the agency’s work and budget priorities. He said the office now oversees adult-use cannabis, medical cannabis, and hemp-derived cannabinoid products, has grown from about nine employees to 90 full-time staff plus temporary workers, and has been working with a Cannabis Advisory Council on testing, warning labels, and implementation issues. He also described outreach efforts, including webinars, newsletters, guidebooks for local governments, and office hours for applicants, along with enforcement of hemp-derived product rules through more than 3,000 inspections and an increase in compliance rates from about 35% to 75%. Toell also reported that the medical cannabis program has surpassed 51,000 patients and nearly 2,500 registered health care providers, and that a chronic pain report found more than a third of patients reported decreased pain. On the adult-use side, he said the office has posted proposed rules for public comment, plans to adopt them after review, and will open a licensing window from February 18 to March 14. He explained that the office is also managing community reinvestment grants and a technical assistance grant, with an emphasis on safeguards to ensure funds reach intended recipients. No votes were taken during this meeting.
TX
Transcript Highlights:
  • of certain products derived from hemp, including consumable hemp products and the hemp-derived cannabinoid
Keywords: 997, house, all
KY
Transcript Highlights:
  • In 2023 we were directed specifically to regulate the hemp-derived cannabinoids.
  • So, we were told to immediately begin regulating hemp-derived cannabinoids.
  • So the products, all the intoxicating products for hemp-derived cannabinoids now have to be regulated
  • This is just like the hemp-derived cannabinoid stuff.
  • We're doing all this work with the hemp-derived cannabinoids.
Keywords: 958, all
Summary: The committee first approved the minutes and then approved an agency amendment to a health and family services regulation. The amendment reversed a prior change so that neonatal ICU beds would remain subject to regular review rather than nonsubstantive review. The remaining administrative regulations were then reviewed without objection. The main presentation was from State Auditor Allison Ball on a report finding $836 million in concurrent Medicaid capitation payments from 2019 through 2022, involving individuals enrolled in Kentucky and at least one other state. Ball said Kentucky relied on the PARIS system, which has limitations because it is updated quarterly and depends on voluntary state participation, while a better federal data source, T-MSIS, was not fully available to the state. She said the audit found weak internal controls, siloed processes, outdated guidance, and a low-priority attitude toward residency checks, all of which contributed to missed alerts and improper payments. She also said the report identified additional problems, including payments made after beneficiaries died and cases involving multiple states paying for the same person. Ball recommended better access to federal data, stronger MCO contract provisions, and more active oversight by the Department for Medicaid Services and managed care organizations. She said the contracts reviewed did not provide a clear way to recoup the improper payments, though she and her counsel suggested possible equitable legal theories might be explored. Members expressed concern about the scale of the waste and the lack of contract enforcement, and asked whether any money could be recovered. Ball said the audit did not identify a clear contractual path to recoup the funds.
HI
Transcript Highlights:
  • There's 150 other cannabinoids that exist in hemp and marijuana because they're cousins, basically.
  • There's 150 other cannabinoids that exist in hemp and marijuana because they're cousins, basically.
  • There's 150 other cannabinoids that exist in hemp and marijuana because they're cousins, basically.
  • There's 150 other cannabinoids that exist in hemp and marijuana because they're cousins, basically.
  • <01:01:53.279> products state law to mean cannabinoid products state law to mean cannabinoid
Keywords: 910, house, all
Summary: The joint hearing opened with House Bill 1462 on crisis services. Testimony from the Department of Law Enforcement, the Community Alliance on Prisons, and the Department of Health supported expanding behavioral health crisis services as an alternative to arrest or incarceration. Witnesses said additional crisis sites would help divert people in mental health crisis to appropriate care, and the Department of Health described its current crisis center in Ewa, including the need for renovations such as a padded room and the time required to get the facility operational. In response to questions, the department estimated the Ewa center’s budgeted cost at about $4.3 million, not including rent or startup repairs, and said a second site’s cost would depend on whether it was freestanding or attached to an existing facility. The committee then heard House Bill 700 on cognitive assessments. The Executive Office on Aging supported the bill’s intent but asked that it be amended to make assessments optional rather than mandated, to pilot the program first, and to allow flexibility in handling HIPAA-protected data. SHPDA also supported the measure but said it should not be mandatory and suggested that payers reimburse for assessments when requested by patients, families, or physicians. The Alzheimer’s Association and caregivers strongly supported standardizing cognitive assessments to improve early detection and access to newer treatments, while noting the existing opt-out provision. The Hawaii State Council on Developmental Disabilities supported the bill but asked that the age 65 threshold be removed because cognitive decline can begin much earlier for people with Down syndrome, autism, traumatic brain injury, stroke, and related conditions. In response to a question, the Office on Aging said a pilot project could likely be done for about $150,000, with data security being the main added cost. The final bill discussed was House Bill 237 on peer support programs. Testimony from Family Hui Hawaii, Early Childhood Action Strategy, peer support workers, and families described peer-to-peer programs as a cost-effective way to reduce isolation, strengthen families, and provide long-term community support. Speakers said these programs help parents and caregivers navigate crises, child welfare involvement, addiction recovery, and other challenges, and can have lasting benefits for children’s development and family stability. Several witnesses tied the bill to broader state goals, including infant and early childhood mental health, trauma-informed care, and child welfare reform. Written testimony from about a dozen organizations and individuals was also noted in support.
MN

Minnesota 2025-2026 Regular Session

Committee on Health and Human Services - 04/01/25

Health and Human Services

Transcript Highlights:
  • She uses hemp-derived cannabinoid oils, some not even available through Minnesota's medical program.
  • She uses hemp-derived cannabinoid oils, some not even available through Minnesota's medical program.
  • She uses hemp-derived cannabinoid oils, some not even available through Minnesota's medical program.
  • She uses hemp-derived cannabinoid oils, some not even available through Minnesota's medical program.
  • She uses hemp-derived cannabinoid oils, some not even available through Minnesota's medical program.
Keywords: 1187, senate, all
HI
Transcript Highlights:
  • pursuant to section 328G-2 may sell, hold, offer, or distribute for sale an edible or beverage cannabinoid
  • pursuant to section 328G-2 may sell, hold, offer, or distribute for sale an edible or beverage cannabinoid
  • The recommendation is adopted. beverage cannabinoid product that beverage cannabinoid product that contains
Keywords: 912, senate, all
Summary: The Health and Human Services Committee heard testimony on several measures related to child welfare, health care access, overdose response, disability services, and waste management. For SB 710 on child welfare, the Department of Human Services, the Office of Wellness and Resilience, the Attorney General’s office, and multiple advocacy groups testified in support, with the Governor’s office noting support but deferring to the Attorney General on implementation because of separation-of-powers concerns. For SB 952 on child welfare services, DHS, the Governor’s office, and child- and trauma-informed care advocates supported the bill, saying it would help families access services, provide basic material support, and reduce strain on the child welfare system. SB 954 on a home health services rate study also drew support, including from DHS, the Hawaii Healthcare Association, and a public testifier who said the study would help ensure funds reach low-income, disabled, and kupuna recipients. SB 957 on overdose prevention received support from the Department of Health and the Attorney General, who said overdose prevention centers are evidence-based but raised federal-law concerns and recommended amendments; the Hawaii Health and Harm Reduction Center and others also testified in support. The committee then moved to the 1:00 regular calendar and heard SB 850 on disability health disparity, which was supported by the Executive Office on Aging, the Hawaii State Council on Developmental Disabilities, the Hawaii Disability Rights Center, self-advocates, and others. Testimony emphasized that a disparity study could improve workforce development, training, and services for people with disabilities. SB 838 on continuous glucose monitoring drew support from health agencies and advocates, with testimony stressing that monitors can be critical for some diabetes patients. SB 829 on health care was supported by the Department of Health and health care stakeholders, who said it would help rotating physicians serve neighbor islands without local hospital privileges and align with CMS rules. SB 446 on waste management drew mixed testimony: the Department of Health and several public entities provided comments, the County of Maui opposed, and environmental advocates urged stronger aquifer protections and limits on ash reuse. During decision making, the committee adopted recommendations to pass SB 298, SB 322, SB 299, SB 450, SB 451, SB 949, SB 710, SB 957, SB 69, and SD 952 with various amendments, including technical changes, blank appropriations, and defective dates. SB 323, SB 324, SB 712, SB 950, SB 954, and SB 959 were deferred, largely because companion House measures were moving or similar Senate measures had already passed. The chair also announced recesses to find quorum and noted that some bills from the earlier Monday calendar were being deferred to avoid duplication.
TX

Texas 89th 2nd C.S.

89th Legislative Session Mar 6th, 2025

Texas House Floor Meeting

Transcript Highlights:
  • Community and Human Services HB 967 by TOTH relating to a study of the prevalence of the use of psychoactive
TX
MA
Transcript Highlights:
  • I don’t know how they do it, but I know they don’t soak it in some sort of synthetic cannabinoid.
  • Soak it in some sort of synthetic cannabinoid and then it’s masked, mixed with Clorox or Pledge, yeah
Keywords: 995, all
Summary: The special commission on consolidation and cooperation among public safety agencies held a hearing focused on union and correctional staff testimony. Chair Dan Hunt and Senator Brownsberger opened by noting the commission’s extensive site visits and prior testimony, and they recognized Correctional Officers Week. Union representatives from KOUF, NCEU, AFSCME, and local county correctional unions described the daily realities of correctional work, emphasizing staff safety, staffing shortages, retention problems, mental health impacts, and the need to preserve local sheriff’s offices and collective bargaining agreements. Testimony centered on several recurring concerns: violence inside facilities, the spread of synthetic drugs such as K2, inmate suicides and suicide attempts, and the strain these issues place on officers, EMS, and local resources. Speakers also raised concerns about gender-identity housing policies, arguing they can create safety and workplace issues for staff, and urged more support for officer wellness, debriefing, and programs like OnSide Academy. Several witnesses argued that county facilities should remain locally controlled and that consolidation with the Department of Correction would weaken programming, staffing, and community-based reentry work. One witness described the Norwegian correctional model as a possible source of ideas for more rehabilitative approaches. Commission members responded with support for correctional staff and asked questions about K2 detection, paperless systems, EMS transports, and possible metrics to quantify incidents and facility needs. Members also discussed the importance of individualized assessments of each facility rather than a one-size-fits-all approach. The commission voted to seek an extension of its reporting deadline from September 30 to November 30, and agreed to continue site visits, including the upcoming Barnstable visit and a June 15 hearing. The meeting adjourned after the motion passed.